F. Lagrange

584 total citations
47 papers, 386 citations indexed

About

F. Lagrange is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, F. Lagrange has authored 47 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 9 papers in Pharmacology and 7 papers in Geriatrics and Gerontology. Recurrent topics in F. Lagrange's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Pharmacy and Medical Practices (6 papers) and Safe Handling of Antineoplastic Drugs (5 papers). F. Lagrange is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Pharmacy and Medical Practices (6 papers) and Safe Handling of Antineoplastic Drugs (5 papers). F. Lagrange collaborates with scholars based in France, Canada and Belize. F. Lagrange's co-authors include Fabienne Péhourcq, B Bannwarth, Karine Titier, Mathiéu Molimard, Nicholas Moore, F Paolucci, J. J. Leng, Myriam Matoga, C. Vergnes and Laurence Labat and has published in prestigious journals such as Thrombosis and Haemostasis, Clinical Pharmacokinetics and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

F. Lagrange

35 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Lagrange France 10 97 88 72 57 54 47 386
Kathrin I. Foerster Germany 13 81 0.8× 198 2.3× 58 0.8× 32 0.6× 26 0.5× 39 651
Claire Gozalo France 12 60 0.6× 89 1.0× 18 0.3× 24 0.4× 131 2.4× 34 491
Laura Hunter United Kingdom 14 66 0.7× 42 0.5× 12 0.2× 53 0.9× 78 1.4× 28 710
Max Taubert Germany 13 31 0.3× 61 0.7× 22 0.3× 19 0.3× 41 0.8× 42 478
S. Hariharan United States 14 37 0.4× 93 1.1× 10 0.1× 101 1.8× 98 1.8× 37 679
Irma H. Benedek United States 10 28 0.3× 89 1.0× 13 0.2× 75 1.3× 40 0.7× 20 509
B. Nhi Beasley United States 5 112 1.2× 181 2.1× 19 0.3× 26 0.5× 27 0.5× 7 575
Man-Wai Lo United States 8 17 0.2× 73 0.8× 14 0.2× 46 0.8× 65 1.2× 10 348
James C. King United States 11 25 0.3× 40 0.5× 18 0.3× 34 0.6× 59 1.1× 26 526
Daniela Sansaro Italy 8 58 0.6× 214 2.4× 20 0.3× 26 0.5× 40 0.7× 14 452

Countries citing papers authored by F. Lagrange

Since Specialization
Citations

This map shows the geographic impact of F. Lagrange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Lagrange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Lagrange more than expected).

Fields of papers citing papers by F. Lagrange

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Lagrange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Lagrange. The network helps show where F. Lagrange may publish in the future.

Co-authorship network of co-authors of F. Lagrange

This figure shows the co-authorship network connecting the top 25 collaborators of F. Lagrange. A scholar is included among the top collaborators of F. Lagrange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Lagrange. F. Lagrange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leblanc, Louis, F. Lagrange, Marc Ladrière, et al.. (2019). Néphrectomie laparoscopique assistée par robot dans le cadre du donneur-vivant : étude chez les donneurs et les receveurs à partir de 155 cas. Progrès en Urologie. 29(12). 596–602. 6 indexed citations
2.
Lagrange, F.. (2016). Bibliothèque. Le Pharmacien Hospitalier et Clinicien. 51(2). 184–184. 1 indexed citations
3.
Lagrange, F.. (2016). Bibliothèque. Le Pharmacien Hospitalier et Clinicien. 51(4). 376–377. 1 indexed citations
4.
Villa, Antoine, et al.. (2014). Expositions accidentelles d’enfants aux détergents liquides en capsules : expérience du centre antipoison de Paris (2011–2012). Archives de Pédiatrie. 21(6). 608–613. 3 indexed citations
5.
Lagrange, F.. (2014). Les œuvres de l’esprit sont du DPC. Le Pharmacien Hospitalier et Clinicien. 49(1). 1–2.
6.
Lagrange, F., et al.. (2014). Developing an innovative oral unit dose robot dispenser: Patient care performance and industrial perspectives. Le Pharmacien Hospitalier et Clinicien. 49(2). e1–e14. 3 indexed citations
7.
Lagrange, F.. (2010). Déconditionnement et stabilité des formes orales sèches solides : états des connaissances. Annales Pharmaceutiques Françaises. 68(6). 332–358. 7 indexed citations
8.
Lagrange, F.. (2010). Prescription en néphrologie : suivi de greffe rénale. 45(4). 200–210. 2 indexed citations
9.
Lagrange, F.. (2009). Prescription d’un traitement antivitamine K. 44(3). 152–157.
10.
11.
Lagrange, F., et al.. (2002). Fondaparinux Sodium Does Not Cross the Placental Barrier*. Clinical Pharmacokinetics. 41(Supplement 2). 47–49. 19 indexed citations
12.
Vergnes, C., et al.. (2002). Absence of Placental Transfer of Pentasaccharide (Fondaparinux, Arixtra®) in the Dually Perfused Human Cotyledon in vitro. Thrombosis and Haemostasis. 87(5). 831–835. 66 indexed citations
13.
Matoga, Myriam, Fabienne Péhourcq, F. Lagrange, F Fawaz, & B Bannwarth. (2002). Influence of a polymeric formulation of ketoprofen on its diffusion into cerebrospinal fluid in rats. Journal of Pharmaceutical and Biomedical Analysis. 27(6). 881–888. 8 indexed citations
14.
Titier, Karine, F. Lagrange, Fabienne Péhourcq, Nicholas Moore, & Mathiéu Molimard. (2002). Pharmacokinetic Interaction Between High-Dose Methotrexate and Oxacillin. Therapeutic Drug Monitoring. 24(4). 570–572. 27 indexed citations
15.
Titier, Karine, et al.. (2002). [Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ].. PubMed. 57(2). 169–74. 5 indexed citations
16.
Lagrange, F., T. Fabre, Fabienne Péhourcq, A. Durandeau, & B Bannwarth. (2001). In vitro distribution of ketoprofen enantiomers in articular tissues of osteoarthritic patients. Journal of Pharmaceutical and Biomedical Analysis. 26(5-6). 717–723. 3 indexed citations
17.
Lagrange, F., et al.. (2001). Placental Transfer of SR49059 in the Human Dually Perfused Cotyledon In Vitro. Placenta. 22(10). 870–875. 9 indexed citations
18.
Lagrange, F., et al.. (1998). Passage of S‐(+)‐ and R‐(‐)‐ketoprofen across the human isolated perfused placenta. Fundamental and Clinical Pharmacology. 12(3). 286–291. 14 indexed citations
19.
Lagrange, F., et al.. (1998). Determination of buprenorphine in plasma by liquid chromatography: application to heroin-dependent subjects. Journal of Pharmaceutical and Biomedical Analysis. 16(8). 1295–1300. 19 indexed citations
20.
Péhourcq, Fabienne, F. Lagrange, Laurence Labat, & B Bannwarth. (1995). Simultaneous Measurement of Flurbiprofen, Ibuprofen, and Ketoprofen Enantiomer Concentrations in Plasma Using L-Leucinamide as the Chiral Coupling Component. Journal of Liquid Chromatography. 18(20). 3969–3979. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin I. Foerster Breakdown of academic impact, for papers by Claire Gozalo Breakdown of academic impact, for papers by Laura Hunter Breakdown of academic impact, for papers by Max Taubert Breakdown of academic impact, for papers by S. Hariharan Breakdown of academic impact, for papers by Irma H. Benedek Breakdown of academic impact, for papers by B. Nhi Beasley Breakdown of academic impact, for papers by Man-Wai Lo Breakdown of academic impact, for papers by James C. King Breakdown of academic impact, for papers by Daniela Sansaro
Rankless by CCL
2026